AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 Genetic Test
Test Name: AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 Genetic Test
Components: Blood Sample
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Dysmorphology
Doctor: Pediatrics
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 NGS Genetic DNA Test gene AKT3
Test Details: The AKT3 gene is associated with a rare genetic disorder called megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 (MPPH2). This syndrome is characterized by several features including an enlarged brain (megalencephaly), abnormal brain folds (polymicrogyria), extra fingers or toes (polydactyly), and accumulation of fluid in the brain (hydrocephalus). NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that can analyze multiple genes simultaneously to identify any mutations or variations that may be present. In the case of MPPH2, NGS testing can be used to analyze the AKT3 gene to identify any genetic changes that may be causing the syndrome. NGS genetic testing can help in confirming a diagnosis of MPPH2 and can also be used for carrier testing, prenatal testing, or for identifying other family members who may be at risk of inheriting the condition. It can provide valuable information for genetic counseling, management, and treatment options for individuals with MPPH2.
Test Name | AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AKT3 Gene Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 NGS Genetic DNA Test gene AKT3 |
Test Details |
The AKT3 gene is associated with a rare genetic disorder called megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome type 2 (MPPH2). This syndrome is characterized by several features including an enlarged brain (megalencephaly), abnormal brain folds (polymicrogyria), extra fingers or toes (polydactyly), and accumulation of fluid in the brain (hydrocephalus). NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that can analyze multiple genes simultaneously to identify any mutations or variations that may be present. In the case of MPPH2, NGS testing can be used to analyze the AKT3 gene to identify any genetic changes that may be causing the syndrome. NGS genetic testing can help in confirming a diagnosis of MPPH2 and can also be used for carrier testing, prenatal testing, or for identifying other family members who may be at risk of inheriting the condition. It can provide valuable information for genetic counseling, management, and treatment options for individuals with MPPH2. |